Immune Therapeutics Inc (OTCQB:IMUN)

0.14
Delayed Data
As of Mar 27
 +0.02 / +16.67%
Today’s Change
0.07
Today|||52-Week Range
0.95
-17.65%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.11 - 0.15
Volume467,817
Average volume (3 months)264,082
Market cap$14.0M
Dividend yield--
Data as of 3:27pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+72.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.62

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$106.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
President &
Chief Operating Officer
Seth A. Elliott
Corporate headquarters
Orlando, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account